ASAS Criteria for Axial Spondyloarthritis (SpA)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۲۰۰ • واحد: months

حداقل ۰ — حداکثر ۱۰۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
classification
—classification
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • —1–1
  • —0–0
  • —-1–-1
Direct Clinical Answer

The ASAS Criteria for Axial Spondyloarthritis (SpA) calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include back pain duration months. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Classifies axial spondyloarthritis according to Assessment of Spondyloarthritis International Society (ASAS) criteria. This classification system allows for early diagnosis of axial SpA by incorporating both clinical and imaging features.

Clinical Indication

The ASAS Criteria for Axial Spondyloarthritis (SpA) is indicated for bedside clinical practice to support Classifies axial spondyloarthritis according to Assessment of Spondyloarthritis International Society (ASAS) criteria. This classification system allows for early diagnosis of axial SpA by incorporating both clinical and imaging features.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology.

Formula & Variables:

Entry criterion: Back pain ≥3 months AND age at onset <45 years. If entry criterion met: Imaging arm (sacroiliitis on imaging + ≥1 SpA feature) OR Clinical arm (HLA-B27 positive + ≥2 SpA features). SpA features include: inflammatory back pain, arthritis, enthesitis, uveitis, dactylitis, psoriasis, Crohn's/colitis, good response to NSAIDs, family history, elevated CRP.

Input Parameters

NameTypeRequiredDescription
back_pain_duration_monthsintegerYesDuration of back pain in months(months)
age_at_onsetintegerYesAge at onset of back pain(years)
sacroiliitis_imagingstringYesSacroiliitis on imaging: X-ray (bilateral grade 2-4 or unilateral grade 3-4) or MRI (active inflammatory lesions suggestive of sacroiliitis associated with SpA)
hla_b27_positivestringYesHLA-B27 positive according to standard laboratory techniques
inflammatory_back_painstringYesInflammatory back pain according to ASAS experts: 4 out of 5 criteria (age at onset <40 years, insidious onset, improvement with exercise, no improvement with rest, pain at night with improvement upon getting up)
arthritisstringYesPast or present active synovitis diagnosed by a doctor
enthesitisstringYesHeel enthesitis: past or present spontaneous pain or tenderness at examination at the site of the insertion of the Achilles tendon or plantar fascia at the calcaneus
uveitisstringYesPast or present anterior uveitis confirmed by an ophthalmologist
dactylitisstringYesPast or present dactylitis diagnosed by a doctor
psoriasisstringYesPast or present psoriasis diagnosed by a doctor
crohns_colitisstringYesPast or present Crohn's disease or ulcerative colitis diagnosed by a doctor
good_response_nsaidsstringYesGood response to NSAIDs: at 24-48h after a full dose of NSAID the back pain is not present anymore or much better
family_historystringYesFamily history: presence in first-degree or second-degree relatives of ankylosing spondylitis, psoriasis, uveitis, reactive arthritis, or inflammatory bowel disease
elevated_crpstringYesCRP above upper normal limit in the presence of back pain, after exclusion of other causes for elevated CRP

Score Interpretation & Guidance

RangeStageDescription
1–1—Meets ASAS criteria for axial spondyloarthritis
0–0—Does not meet ASAS criteria
-1–-1—Entry criterion not fulfilled

Evidence-Based References (EBM)

  • Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777-83.
  • Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl 2:ii1-44.
  • Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann Rheum Dis. 2009;68(6):784-8.

Related calculators